Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA), seeking approval of IMAAVY® ...
Johnson & Johnson (NYSE:JNJ) reported encouraging early clinical results for its prostate cancer therapy pasritamig and is ...
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) is one of the best up and coming penny stocks to buy. On February 2, 60 Degrees ...
On January 28, SlateStone Wealth chief market strategist Kenny Polcari discussed small-cap stock performance on FOX Business ...
Fulcrum Therapeutics, Inc. ( FULC) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST Good morning, and welcome to the Fulcrum Therapeutics conference call to discuss 12-week data from the ...
DaVita Inc. today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor ...
Poor sleep is linked to significantly higher rates of self-injury, suicidal thoughts and aggression among autistic children ...
Blackstone Life Sciences announced a research and development funding agreement to advance the clinical development of ...
Sanofi has obtained orphan drug designation in Japan for rilzabrutinib as a treatment for IgG4-related disease, a rare immune-mediated condition with limited treatment options. The designation from ...
Popular acid reflux drugs such as Prilosec, Nexium, and Protonix may carry hidden risks when taken long term. A new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results